INS and type 1 diabetes mellitus: Differentiating patient-derived iPSCs to functional cell types such as insulin-producing beta-cells for restoring the function of the pancreatic endocrine cells in Type I diabetes patients is an attractive long-term aim in the regenerative medicine field.